Advance Nanotech, A Commercial Partner in FLUTEST, Part Of The European Commission’s Support To Combat The Spread Of Avian Influenza

NEW YORK--(BUSINESS WIRE)--Advance Nanotech, Inc., (OTCBB:AVNA), the premier provider of financing and support services to drive the commercialization of nanotechnology related products for Homeland Security and Display technologies today announced that it has been selected to participate in FLUTEST, a European Commission supported research project for improved diagnosis and early warning systems for avian influenza outbreak management, commonly referred to as “bird flu.”